Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 17.55
-0.05 (-0.28%)
Last updated: Aug 7, 2026, 11:34 AM CET
Vytrus Biotech Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 132 | 64 | 16 | 22 | 23 | - | |
Market Cap Growth | 219.67% | 289.69% | -25.35% | -2.52% | - | - |
Enterprise Value | 130.09 | 61.33 | 16.39 | 23.84 | 23.96 | 0 |
Last Close Price | 17.55 | 8.55 | 2.16 | 3.28 | 3.28 | - |
PE Ratio | 45.67 | 22.50 | 16.62 | 41.00 | 36.44 | - |
Forward PE | - | 20.43 | 21.98 | 11.97 | 26.21 | - |
PS Ratio | 13.65 | 7.68 | 3.27 | 5.91 | 6.15 | - |
PB Ratio | 12.83 | 6.43 | 2.31 | 4.38 | 4.86 | - |
P/TBV Ratio | 1637.56 | 797.78 | - | 16.49 | 15.48 | - |
P/FCF Ratio | 45.83 | 22.26 | 9.46 | 28.96 | 37.42 | - |
P/OCF Ratio | 33.92 | 16.48 | 8.94 | 24.43 | 22.09 | - |
EV/Sales Ratio | 13.42 | 7.33 | 3.25 | 6.38 | 6.51 | - |
EV/EBITDA Ratio | 31.31 | 14.76 | 8.93 | 20.21 | 17.93 | - |
EV/EBIT Ratio | 40.90 | 19.28 | 16.31 | 52.48 | 37.17 | - |
EV/FCF Ratio | 45.07 | 21.25 | 9.40 | 31.25 | 39.56 | - |
Debt / Equity Ratio | 0.38 | 0.38 | 0.68 | 0.54 | 0.43 | 0.89 |
Debt / EBITDA Ratio | 0.95 | 0.95 | 2.70 | 2.42 | 1.52 | 3.75 |
Debt / FCF Ratio | 1.37 | 1.37 | 2.84 | 3.74 | 3.34 | 16.60 |
Net Debt / Equity Ratio | -0.29 | -0.29 | -0.01 | 0.35 | 0.28 | 0.29 |
Net Debt / EBITDA Ratio | -0.71 | -0.71 | -0.06 | 1.48 | 0.97 | 1.20 |
Net Debt / FCF Ratio | -1.02 | -1.02 | -0.06 | 2.29 | 2.15 | 5.30 |
Asset Turnover | 0.65 | 0.65 | 0.49 | 0.43 | 0.48 | 0.42 |
Inventory Turnover | 0.78 | 0.78 | 0.65 | 0.96 | 0.83 | 0.61 |
Quick Ratio | 5.12 | 5.12 | 5.09 | 1.83 | 0.93 | 3.75 |
Current Ratio | 3.03 | 3.03 | 3.03 | 2.46 | 1.33 | 2.26 |
Return on Equity (ROE) | 32.91% | 32.91% | 16.23% | 10.85% | 13.44% | 11.45% |
Return on Assets (ROA) | 22.85% | 22.85% | 11.13% | 9.27% | 11.35% | 9.34% |
Return on Invested Capital (ROIC) | 39.97% | 40.48% | 15.99% | 12.26% | 14.97% | 11.72% |
Return on Capital Employed (ROCE) | 27.94% | 27.94% | 11.04% | 6.04% | 9.83% | 7.19% |
Earnings Yield | 2.19% | 4.44% | 6.02% | 2.44% | 2.74% | - |
FCF Yield | 2.18% | 4.49% | 10.57% | 3.45% | 2.67% | - |
Buyback Yield / Dilution | 0.10% | 0.00% | -7.31% | 0.00% | -1.64% | 0.00% |
Total Shareholder Return | 0.10% | 0.00% | -7.31% | 0.00% | -1.64% | 0.00% |